Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine.
Saved in:
| Title: | Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine. |
|---|---|
| Authors: | Tomlin S; Director Children's Medicines Research and Innovation Centre, Great Ormond Street Hospital for Children, London, WC1N 1EP, UK., Mühlhausen C; Department of Paediatrics and Adolescent Medicine, University Medical Center, Georg-August University, Göttingen, Germany., Krendyukov A; Medical Office, Aspire Pharma Ltd., 4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, UK. ankov.de@outlook.com., Das AM; Department of Paediatrics, Clinic for Paediatric Kidney, Liver- and Metabolic Diseases and Neuropaediatrics, Hannover Medical School, Carl Neuberg Str. 1, 30625, Hannover, Germany. |
| Source: | Pharmaceutical medicine [Pharmaceut Med] 2026 Jul; Vol. 40 (4), pp. 275-285. Date of Electronic Publication: 2026 Jun 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101471195 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1993 (Electronic) Linking ISSN: 11782595 NLM ISO Abbreviation: Pharmaceut Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1993 |
|---|---|
| DOI: | 10.1007/s40290-026-00611-3 |
